Contact
Please use this form to send email to PR contact of this press release:
Denali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients
TO:
Please use this form to send email to PR contact of this press release:
Denali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients
TO: